Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment-Reference-Cited by-同舟云学术

Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment

Published:2014-11 Issue:3 Volume:88 Page:746-758
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Chirio Daniela,Gallarate Marina,Peira Elena,Battaglia Luigi,Muntoni Elisabetta,Riganti Chiara,Biasibetti Elena,Capucchio Maria Teresa,Valazza Alberto,Panciani Pierpaolo,Lanotte Michele,Annovazzi Laura,Caldera Valentina,Mellai Marta,Filice Gaetano,Corona Silvia,Schiffer Davide

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference53 articles.

1. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges;Nicholas;Semin. Oncol.,2011

2. Novel diagnostic and therapeutic approaches to malignant glioma;Weller;Swiss Med. Wkly.,2011

3. Drug resistance in brain diseases and the role of drug efflux transporters;Loscher;Nat. Rev. Neurosci.,2005

4. The blood–brain barrier/neurovascular unit in health and disease;Hawkins;Pharmacol. Rev.,2005

5. Barriers in the brain: a renaissance?;Saunders;Trends Neurosci.,2008

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in nanoengineered paclitaxel formulations: A comprehensive review of blood-brain barrier infiltration strategies for glioblastoma therapy;Biomedical Engineering Advances;2024-06

2. Cancer nanomedicine: emergence, expansion, and expectations;SN Applied Sciences;2023-12

3. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials;Journal of Liposome Research;2023-05-05

4. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities;AAPS PharmSciTech;2023-04-11

5. Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells;Colloids and Surfaces B: Biointerfaces;2022-12